| Date | Title | Description | |
|---|---|---|---|
| 26 Jul 2023 | On buy-back programmes | The Company reports the commencement, effective as of today, 26 July 2023, of a share buyback program. | Download |
| 10 May 2023 | On P&L | The Company releases the first quarter 2023 financial results presentation | Download |
| 10 May 2023 | On P&L | The Company releases the press release related to the first quarter 2023 financial results | Download |
| 25 Apr 2023 | On business and financial situation | ROVI commences clinical development of a new three-monthly formulation of Letrozole (Letrozole LEBE) | Download |
| 21 Feb 2023 | On business and financial situation | The company releases the Integrated Report for the year 2022 | Download |
Pages
| Date | Title | Description | |
|---|---|---|---|
| 02 Apr 2020 | On business and financial situation | ROVI informs on the impact of Covid‑19 on the company’s activities | Download |
| 26 Feb 2020 | Information on P&L | ROVI releases the press release related to the full year 2019 financial results | Download |
| 26 Feb 2020 | Information on P&L | ROVI releases the full year 2019 results presentation | Download |
| 26 Feb 2020 | About corporate governance | The Company informs about the agreements adopted by the Board of Directors | Download |
| 26 Feb 2020 | Annual Corporate Governance Report | ROVI releases the 2019 Annual Corporate Governance Report | Download |